Tuesday, October 18, 2022
Cancer vaccine could be ready for use by 2030, say BioNTech founders
According to Uğur Şahin and Özlem Türeci, the founders of the German company BioNTech, mRNA vaccines that can help target cancer could be ready for …
* View the article originally published here. ** More curations: Al Cannistra at San Antonio ONE here.